Relmada Therapeutics Inc (RLMD)
3.53
-0.30
(-7.83%)
USD |
NASDAQ |
Apr 29, 16:00
3.535
0.00 (0.00%)
After-Hours: 20:00
Relmada Therapeutics Market Cap: 106.51M for April 29, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 29, 2024 | 106.51M |
| April 26, 2024 | 115.57M |
| April 25, 2024 | 111.64M |
| April 24, 2024 | 116.47M |
| April 23, 2024 | 117.98M |
| April 22, 2024 | 116.77M |
| April 19, 2024 | 120.70M |
| April 18, 2024 | 129.75M |
| April 17, 2024 | 141.22M |
| April 16, 2024 | 137.59M |
| April 15, 2024 | 134.28M |
| April 12, 2024 | 140.31M |
| April 11, 2024 | 140.61M |
| April 10, 2024 | 136.09M |
| April 09, 2024 | 144.84M |
| April 08, 2024 | 146.65M |
| April 05, 2024 | 138.50M |
| April 04, 2024 | 141.52M |
| April 03, 2024 | 142.12M |
| April 02, 2024 | 149.06M |
| April 01, 2024 | 147.25M |
| March 28, 2024 | 140.31M |
| March 27, 2024 | 138.50M |
| March 26, 2024 | 141.52M |
| March 25, 2024 | 147.85M |
| Date | Value |
|---|---|
| March 22, 2024 | 146.65M |
| March 21, 2024 | 140.61M |
| March 20, 2024 | 133.82M |
| March 19, 2024 | 162.04M |
| March 18, 2024 | 166.56M |
| March 15, 2024 | 163.54M |
| March 14, 2024 | 151.40M |
| March 13, 2024 | 169.76M |
| March 12, 2024 | 166.45M |
| March 11, 2024 | 173.67M |
| March 08, 2024 | 191.13M |
| March 07, 2024 | 191.73M |
| March 06, 2024 | 192.63M |
| March 05, 2024 | 190.23M |
| March 04, 2024 | 191.13M |
| March 01, 2024 | 204.67M |
| February 29, 2024 | 184.36M |
| February 28, 2024 | 184.81M |
| February 27, 2024 | 178.49M |
| February 26, 2024 | 177.89M |
| February 23, 2024 | 170.96M |
| February 22, 2024 | 166.75M |
| February 21, 2024 | 171.26M |
| February 20, 2024 | 179.39M |
| February 16, 2024 | 168.25M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
53.60M
Minimum
May 03 2019
1.060B
Maximum
Sep 30 2022
390.57M
Average
458.02M
Median
Oct 08 2021
Market Cap Benchmarks
| Cyclacel Pharmaceuticals Inc | 1.793M |
| Lifecore Biomedical Inc | 197.33M |
| Corvus Pharmaceuticals Inc | 77.48M |
| NeuroBo Pharmaceuticals Inc | 15.85M |
| Ensysce Biosciences Inc | 4.346M |
Market Cap Related Metrics
| PEG Ratio | -0.987 |
| Price to Book Value | 1.248 |
| Price | 3.53 |
| Earnings Yield | -92.63% |
| PEGY Ratio | -0.987 |